Andrew Reardon serves as Executive at LIGAND PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Andrew Reardon has executed 16 insider transactions totaling $1.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 10, 2025 involved selling 1,325 shares valued at $198.8K.
Andrew Reardon currently holds 30,811 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Reardon has been a net seller of LGND stock. They have purchased $0 and sold $1.2M worth of shares.
Andrew Reardon's most recent insider trade was on Aug 10, 2025, when they sold 1,325 shares at $150.06 per share.
Get notified when new Form 4 filings are submitted
| $91.08 |
| Discretionary |
| Sep 23, 2024 | LGND | $199.2K | Sale | 2,000 | $99.60 | Discretionary |
| Sep 23, 2024 | LGND | $104.5K | Option Exercise | 2,000 | $52.27 | Discretionary |
| Aug 28, 2024 | LGND | $78.4K | Option Exercise | 1,500 | $52.27 | Discretionary |
| Aug 28, 2024 | LGND | $159.6K | Sale | 1,500 | $106.39 | Discretionary |
| Jun 28, 2024 | LGND | $20.0K | Other | 329 | $60.71 | Discretionary |
| May 9, 2024 | LGND | $830.4K | Sale | 10,000 | $83.04 | Discretionary |
| May 9, 2024 | LGND | $522.7K | Option Exercise | 10,000 | $52.27 | Discretionary |
| Feb 27, 2024 | LGND | $0 | Award | 7,208 | $N/A | Discretionary |
| Feb 15, 2024 | LGND | $44.3K | Payment | 593 | $74.65 | Discretionary |
| Dec 29, 2023 | LGND | $10.9K | Other | 179 | $60.71 | Discretionary |
| Aug 10, 2023 | LGND | $61.7K | Payment | 897 | $68.73 | Discretionary |
| Mar 24, 2023 | LGND | $21.0K | Sale | 300 | $69.92 | Discretionary |
| Feb 23, 2023 | LGND | $0 | Award | 5,668 | $N/A | Discretionary |
| Nov 30, 2022 | LGND | $78.2K | Payment | 1,073 | $72.90 | Discretionary |